Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Leukemia|October 14, 2022
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAPJulia Driessen, Marie José Kersten, Lydia Visser, et al.
The Lancet. Oncology|July 13, 2025
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trialJustin Ferdinandus, Gundolf Schneider, Alden Moccia, et al.
Blood Advances|May 4, 2021
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patientsJ J Eertink, C N Burggraaff, M W Heymans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study GroupMichael Fuchs, Helen Goergen, Carsten Kobe, et al.
Neuro-Oncology|December 1, 2023
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 studyJacoline E C Bromberg, Samar Issa, Bronno van der Holt, et al.
Journal of the National Cancer Institute|April 13, 2026
The impact of survivorship care on burden of disease among Hodgkin lymphoma survivorsEline Mj Lammers, Josée M Zijlstra, Michael Schaapveld, et al.
Journal of Inherited Metabolic Disease|January 18, 2023
MOGS-CDG: Quantitative analysis of the diagnostic Glc3 Man tetrasaccharide and clinical spectrum of six new casesMerel A Post, Isis de Wit, Fokje S M Zijlstra, et al.
The Lancet. Haematology|May 4, 2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumoursCristina Nanni, Carsten Kobe, Bettina Baeßler, et al.
Nature Communications|January 2, 2025
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphomaMatías S Mendeville, Jurriaan Janssen, G Tjitske Los-de Vries, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled TrialAnouk S Schuit, Karen Holtmaat, Veerle M H Coupé, et al.
Pageof 23